Absci Corp. (ABSI)
3.645
-0.20
(-5.08%)
USD |
NASDAQ |
Dec 12, 16:00
3.69
+0.04
(+1.23%)
After-Hours: 17:28
Absci Research and Development Expense (Quarterly): 19.25M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| CorMedix, Inc. | 5.098M |
| Verastem, Inc. | 28.99M |
| Fortress Biotech, Inc. | 0.208M |
| Anavex Life Sciences Corp. | 7.295M |
| Ocugen, Inc. | 10.20M |